The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the portal hypertension management market’s growth in recent years?
An increasing prevalence of liver diseases such as hepatitis is expected to propel the growth of the portal hypertension management market going forward. Liver disease refers to a range of conditions that affect the liver’s structure or function, often leading to symptoms such as jaundice, fatigue, and abdominal pain, with causes including viral infections, alcohol abuse, or metabolic disorders. Liver diseases are occurring due to alcohol consumption, viral hepatitis infections, obesity-related fatty liver disease, and metabolic disorders. Portal hypertension management in liver disease aims to reduce pressure in the portal vein system, which helps alleviate complications such as variceal bleeding, ascites, and hepatic encephalopathy, improving patient outcomes. For instance, in September 2022, according to Cancer Australia, an Australia-based government cancer agency, around 2,905 new cases of liver cancer were diagnosed in Australia in 2022 (2,113 males and 792 females). Further, the risk of developing liver cancer by age 85 is predicted to be 1 in 103 (or 0.97%) in 2022, 1 in 70, or 1.4%, for men, and 1 in 195, or 0.51%, for women. Therefore, the increasing prevalence of liver diseases is driving the portal hypertension management market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16515&type=smp
How does the future projection of the portal hypertension management market size compare to its historical growth?
The portal hypertension management market size has grown strongly in recent years. It will grow from $3.07 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to the increased prevalence of liver diseases, growth in the geriatric population, awareness and screening programs, economic burden of liver diseases, approval done for new drugs and therapies, and improvement done for diagnostic methods.
The portal hypertension management market size is expected to see strong growth in the next few years. It will grow to $4.23 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising investment in healthcare infrastructure, broader health insurance coverage, favorable regulatory environments and expedited approval processes, ongoing r&d activities focused on understanding the pathophysiology of portal hypertension, and remote monitoring technologies will facilitate continuous patient management. Major trends in the forecast period include growing adoption of telemedicine, continued advancements in medical technology, such as bio-engineered liver tissue, growth in personalized medicine, development of targeted therapies tailored to individual patient profiles, improved diagnostic methods, including non-invasive imaging technologies like elastography.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=16515&type=smp
Which key players are shaping the future of the portal hypertension management market?
Major companies operating in the portal hypertension management market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Merck & Co., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals LLC., Lupin Ltd., Daiichi Sankyo, Dr. Falk Pharma GmbH, Cumberland Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Chiasma Inc., Debiovision Inc.
What trends will propel the growth and evolution of the portal hypertension management market?
Major companies in the portal hypertension management market are adopting advanced minimally invasive devices to enhance treatment outcomes and reduce procedural risks. Minimally invasive devices are medical instruments or tools designed to perform procedures with minimal disruption to surrounding tissues, typically through small incisions or natural body openings. For instance, in November 2023, Medtronic Plc, a US-based medical device manufacturer, received approval from the U.S. Food and Drug Administration (FDA) for Symplicity Spyral renal denervation (RDN). It is a minimally invasive device for treating hypertension. This innovative procedure employs radiofrequency energy to target nerves near the kidneys, effectively calming them to manage hypertension.
Which regions are expected to become dominant players in the portal hypertension management market?
North America was the largest region in the portal hypertension management market in 2023. The regions covered in the portal hypertension management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
What are the emerging key segments in the portal hypertension management market, and how are they evolving?
The portal hypertension management market covered in this report is segmented –
1) By Treatment Type: Medications, Non-Surgical Procedures, Surgery
2) By Procedure Type: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Other Procedure Types
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Medications: Beta-Blockers, Vasodilators, Diuretics, Antibiotics, Other Medications
2) By Non-Surgical Procedures: Endoscopic Variceal Ligation (EVL), Endoscopic Sclerotherapy, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Balloon Occlusion
3) By Surgery: Liver Transplantation, Portosystemic Shunt Surgery, Surgical Decompression Of Portal Vein, Other Surgical Procedures
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16515
How is the portal hypertension management market defined, and what are its core characteristics?
Portal hypertension management refers to the treatment and prevention of complications arising from increased pressure in the portal vein system, often due to liver cirrhosis. It involves measures to reduce portal pressure, such as lifestyle changes, medications (like beta-blockers), and procedures such as variceal banding placement to prevent or manage complications such as variceal bleeding and ascites.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
